Press Releases from DelveInsight Business Research (5777 total)
Familial Chylomicronemia Syndrome Pipeline Analysis 2024: FDA Approvals and Emer …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Familial Chylomicronemia Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Familial…
Hypercholesterolemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hypercholesterolemia pipeline constitutes 25+ key companies continuously working towards developing 30+ Hypercholesterolemia treatment therapies,…
Cystic Fibrosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Cystic Fibrosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Cystic Fibrosis treatment therapies, analysis…
Acute Ischemic Stroke Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication …
(Albany, USA) As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Acute Ischemic Stroke…
Bronchopulmonary Dysplasia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's, "Bronchopulmonary Dysplasia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Bronchopulmonary Dysplasia pipeline landscape. It…
Critical Limb Ischemia Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinica …
(Albany, United States) As per DelveInsight's assessment, globally, Critical Limb Ischemia pipeline constitutes 10+ key companies continuously working towards developing 15+ Critical Limb Ischemia treatment…
Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, United States) Colorectal Cancer pipeline constitutes 195+ key companies continuously working towards developing 200+ Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism…
Cell and Gene Therapies in Rare Disorders Market to Reach New Heights in Growth …
DelveInsight's "Cell and Gene Therapies in Rare Disorders Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cell and Gene Therapies…
Generalized Anxiety Disorder Pipeline 2024: Clinical Trials Assessment, FDA Appr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Generalized Anxiety Disorder pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized…
Multiple Myeloma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Myeloma pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Myeloma…
Multiple System Atrophy Pipeline Update 2024: FDA Approvals, Therapeutic Advance …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple…
Metastatic Prostate Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approv …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Prostate Cancer pipeline constitutes 80+ key companies continuously working towards developing 85+ Metastatic…
Acute Pancreatitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Companies, Me …
(Albany, United States) As per DelveInsight's assessment, globally, Acute Pancreatitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Acute Pancreatitis treatment therapies, analysis…
Chemotherapy Induced Peripheral Neuropathy Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, United States) As per DelveInsight's assessment, globally, Chemotherapy Induced Peripheral Neuropathy pipeline constitutes 10+ key companies continuously working towards developing 11+ Chemotherapy Induced Peripheral…
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Companies, Me …
(Albany, USA) "Cholangiocarcinoma Pipeline Insight 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cholangiocarcinoma Market.
The…
Congenital Adrenal Hyperplasia Clinical Trials 2024: EMA, PDMA, FDA Approvals, C …
(Albany, United States) Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards developing 8+ Congenital Adrenal Hyperplasia treatment therapies, analysis of Clinical Trials,…
Corneal Ulcer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, USA) DelveInsight's, "Corneal Ulcer Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Corneal Ulcer pipeline landscape. It…
Ulcerated Necrobiosis Lipoidica Market is Predicted to Exhibit Remarkable Growth …
DelveInsight's "Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as…
Underactive Bladder Market Growth to Accelerate in Forecast Period (2024-2034), …
DelveInsight's "Underactive Bladder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Underactive Bladder, historical and forecasted epidemiology as well as…
WHIM Syndrome Pipeline Analysis 2024: FDA Approvals and Emerging Therapies, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, WHIM Syndrome pipeline constitutes key companies continuously working towards developing WHIM Syndrome treatment therapies,…
Cancer Vaccines Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines…
CDKL5 Deficiency Disorder Pipeline 2024: Clinical Trials Assessment, FDA Approva …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CDKL5 Deficiency Disorder pipeline constitutes 7+ key companies continuously working towards developing 8+ CDKL5…
Menkes Disease Market 2034: Epidemiology Review, Pipeline Breakthroughs, Regulat …
DelveInsight's "Menkes Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as…
Microscopic Polyangiitis Market 2034: Epidemiology Trends, Innovative Therapies, …
DelveInsight's "Microscopic Polyangiitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Microscopic Polyangiitis, historical and forecasted epidemiology as well as…
Migraine Pipeline Analysis 2024: FDA Approvals and Emerging Therapies | GlaxoSmi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Migraine pipeline constitutes 30+ key companies continuously working towards developing 30+ Migraine treatment therapies,…
Influenza Pipeline Insights 2024: Therapies, Clinical Trials, Therapies, Mechani …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies,…
Severe Asthma Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapie …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Severe Asthma pipeline constitutes key companies continuously working towards developing Severe Asthma treatment therapies,…
Vascular Dementia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, United States) As per DelveInsight's assessment, globally, Vascular Dementia pipeline constitutes 11+ key companies continuously working towards developing 11+ Vascular Dementia treatment therapies, analysis…
Uncomplicated Urinary Tract Infections Clinical Trials 2024: EMA, PDMA, FDA Appr …
(Albany, United States) As per DelveInsight's assessment, globally, Uncomplicated Urinary Tract Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Uncomplicated Urinary Tract…
Cervical Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, USA) DelveInsight's, "Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It…
Alzheimer's Disease Pipeline Drugs 2024: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 110+ key companies continuously working towards developing 120+ Alzheimer's Disease treatment therapies, analysis…
Neurotrophic Keratitis Pipeline Analysis 2024: FDA Approvals, Clinical Trials, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neurotrophic Keratitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Neurotrophic Keratitis treatment…
Vernal Keratoconjunctivitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medi …
(Albany, United States) As per DelveInsight's assessment, globally, Vernal Keratoconjunctivitis pipeline constitutes 5+ key companies continuously working towards developing 5+ Vernal Keratoconjunctivitis treatment therapies, analysis…
Myasthenia Gravis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …
(Albany, USA) As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Myasthenia Gravis therapeutics landscape…
Myelodysplastic Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the…
Spastic Cerebral Palsy Pipeline Overview 2024: FDA Approvals, Analysis of Clinic …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spastic Cerebral Palsy pipeline constitutes key companies continuously working towards developing Spastic Cerebral Palsy…
Charcot Marie Tooth Disease Pipeline Analysis 2024: FDA Approvals and Emerging T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 15+…
Checkpoint Inhibitor Refractory Cancer Market Forecasted to Surge in Coming Year …
DelveInsight's "Checkpoint Inhibitor Refractory Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Checkpoint Inhibitor Refractory Cancer, historical and forecasted…
Duchenne Muscular Dystrophy Pipeline Insights 2024: Therapies, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne…
Dyslipidemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dyslipidemia pipeline constitutes key companies continuously working towards developing Dyslipidemia treatment therapies, analysis of…
Alcohol Use Disorder Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …
(Albany, USA) DelveInsight's, "Alcohol Use Disorder Pipeline Insight, 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical Trials 2024: EMA, …
(Albany, USA) DelveInsight's, "AAV Vectors in Gene Therapy Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 235+ pipeline drugs in AAV vectors…
Adrenocortical Carcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …
(Albany, United States) As per DelveInsight's assessment, globally, Adrenocortical Carcinoma pipeline constitutes 5+ key companies continuously working towards developing 5+ Adrenocortical Carcinoma treatment therapies, analysis…
Acute Lymphocytic Leukemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medic …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia…
Age-related Vision Dysfunction Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Age-related Vision Dysfunction pipeline constitutes 8+ key companies continuously working towards developing 8+ Age-related Vision Dysfunction treatment…
Chlamydia Infections Clinical Trials 2024: FDA Approvals, Clinical Trials, Thera …
(Albany, USA) DelveInsight's, "Chlamydia Infections Pipeline Insight, 2024," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia Infections pipeline landscape. It…
Treatment Resistant Depression Pipeline Analysis 2024: FDA Approvals, Clinical T …
(Albany, United States) As per DelveInsight's assessment, globally, Treatment Resistant Depression pipeline constitutes 25+ key companies continuously working towards developing 25+ Treatment Resistant Depression treatment…
Usher Syndrome Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Albany, United States) As per DelveInsight's assessment, globally, Usher Syndrome pipeline constitutes 5+ key companies continuously working towards developing 7+ Usher Syndrome treatment therapies, analysis…
Renal Tubular Acidosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Renal Tubular Acidosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Renal Tubular Acidosis treatment…
Venous Thromboembolism Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Venous Thromboembolism pipeline constitutes 10+ key companies continuously working towards developing 10+ Venous Thromboembolism treatment therapies, analysis…
